313348 27 5 Suppliers USA
Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
Product | Description | |
---|---|---|
Regadenoson Quick inquiry Where to buy Suppliers range | Regadenoson. Group: Heterocyclic Organic Compound. CAS No. 313348-27-5. Product ID: ACM313348275. Molecular formula: C15H18N8O5. | |
Regadenoson Quick inquiry Where to buy Suppliers range | Regadenoson, as a coronary vasodilator it is a selective A2A adenosine receptor agonist in myocardial imaging. Uses: A selective a2a adenosine receptor agonist in myocardial imaging. Synonyms: 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide CVT 3146 CVT-3146 CVT3146 Lexiscan regadenoson. Grades: >99%. CAS No. 313348-27-5. Molecular formula: C15H18N8O5. Mole weight: 390.35. | |
Regadenoson Quick inquiry Where to buy Suppliers range | Regadenoson, 313348-27-5, Lexiscan, Rapiscan, CVT-3146, Lexiscan (TN), Regadenoson anhydrous, CVT 3146, Regadenoson [USAN:INN], UNII-7AXV542LZ4, 2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine, 7AXV542LZ4, CHEMBL317052, DTXSID4057712, 1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide, Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-, Regadenoson monohydrate, C15H18N8O5, 1-(6-Amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide, (1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide, 1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide, Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-, REGADENOSON [MI], REGADENOSON [INN], Regadenoson (USAN/INN), D0XE1C, Regadenoson; CVT-3146, REGADENOSON [MART.], SCHEMBL678893, GTPL5596, DTXCID5031501, CHEBI:135613, HMS3886O21, AMY27715, EX-A2148, HY-A0168, Tox21_113668, BDBM50119132, s5358, AKOS026750593, C15-H18-N8-O5, CCG-268525, CS-5612, CV-3146, DB06213, NCGC00249892-01, AC-35838, AS-56292, BP-58629, LS-193008, CAS-313348-27-5, CVT-3146;CVT3146;CVT 3146, D05711, EN300-19633972, J-018384, Q7307897, (1-{9-[(4s,2r,3r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-n-methylcarboxamide, 1-[6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-2-yl]-1H-pyrazole-4-carboxylic acid methylamide, 6-Amino-2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]purine-9-yl-beta-D-ribofuranoside;1-(6-amino-9-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yloxy)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide. |